Improve Research Reproducibility A Bio-protocol resource
bpdetail_icon_lock
Preprint

Statistical analysis

ES Elisa Scarselli
LP Luigia Pace

Last updated date: Aug 12, 2022 Views: 528 Forks: 0

original An abbreviated version of this protocol was published in Science Translational Medicine in Aug, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection
download pdf Download PDF
ask Ask a question
cite How to cite
nfavorite Favorite

Related files

pdf nous-209-01-protocol_Redacted_Def.pdf download
Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
  1. Scarselli, E and Pace, L(2022). Statistical analysis. Bio-protocol Preprint. bio-protocol.org/prep1857.
  2. D’Alise, A. M., Brasu, N., De Intinis, C., Leoni, G., Russo, V., Langone, F., Baev, D., Micarelli, E., Petiti, L., Picelli, S., Fakih, M., Le, D. T., Overman, M. J., Shields, A. F., Pedersen, K. S., Shah, M. A., Mukherjee, S., Faivre, T., Delaite, P., Scarselli, E. and Pace, L.(2022). Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection. Science Translational Medicine 14(657). DOI: 10.1126/scitranslmed.abo7604

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A
This protocol preprint was submitted via the "Request a Protocol" track.